Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.4.22.69 extracted from

  • Tiyoula, F.T.; Aryapour, H.
    Reconstruction of the unbinding pathways of noncovalent SARS-CoV and SARS-CoV-2 3CLpro inhibitors using unbiased molecular dynamics simulations (2022), PLoS One, 17, e0263251 .
    View publication on PubMedView publication on EuropePMC

Inhibitors

Inhibitors Comment Organism Structure
1-(4-methylpiperazin-1-yl)-2-(1H-pyrrolo[2,3-b]pyridin-3-yl)ethan-1-one in the binding pose, the 1,4-dimethylpiperazine fragment has only pi-sulfur interaction with Met165, the pyrrolo[2,3-b] pyridine fragment of the inhibitor is in van der Waals and amino-pi interactions with Asn142, van der Waals interaction with Glu166, and has polar-pi interaction with Ser144 and cation-pi interactions with His163 Severe acute respiratory syndrome coronavirus 2
N-(4-tert-butylphenyl)-N-[(1R)-2-(cyclohexylamino)-2-oxo-1-(pyridin-3-yl)ethyl]-1H-imidazole-4-carboxamide compound shows a broad spectrum of anti-viral activities. Water molecules enter the free binding S regions and weaken protein-inhibitor fundamental interactions gradually. N142, G143, and H163 are the essential residues, which cause key protein-ligand interactions Severe acute respiratory syndrome coronavirus 2
N-[(1R)-2-(tert-butylamino)-2-oxo-1-(pyridin-3-yl)ethyl]-N-(4-tert-butylphenyl)furan-2-carboxamide noncovalent inhibitor, evaluation of unbinding pathways severe acute respiratory syndrome coronavirus
N-[4-(acetylamino)phenyl]-2-(1H-benzotriazol-1-yl)-N-[(1R)-2-[(2-methylbutan-2-yl)amino]-1-(1-methyl-1H-pyrrol-2-yl)-2-oxoethyl]acetamide noncovalent inhibitor, evalutation of unbinding pathways, Met49 and Gln189 are important residues for interactions severe acute respiratory syndrome coronavirus

Organism

Organism UniProt Comment Textmining
severe acute respiratory syndrome coronavirus P0C6U8 replicase polyprotein 1a
-
Severe acute respiratory syndrome coronavirus 2 P0DTD1 replicase polyprotein 1ab
-